¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"PMN"¿¡ ´ëÇÑ ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
PMN Phagocytic white blood cells with a lobed nucleus.
Ãâó: www.genpromag.com/Glossary~LETTER~P.html
PMN polymorphonuclear leukocyte; neutrophil.
Ãâó: www.uwo.ca/pathol/glossary.html
PMN has the meaning described in 40 CFR part 720, subpart A promulgated under the Toxic Substances Control Act, 15 USC 2601 et seq.
Ãâó: www.setonresourcecenter.com/cfr/40CFR/P82_096.HTM
PMN A premarket notification [510(k)] is a marketing application submitted to FDA to demonstrate that a medical device is as safe and as effective or substanntially equivalent to a legally marketed device that was or is currently on he USA market and that does not require premarket approval. The premarket notification (PMN) requirements are found in 21 CFR Psrt 807, Subpart E.
Ãâó: www.chomericstest.com/news/glossary.htm
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á